1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPharmaceutical Take-Back Program (Funding-Only Grant) is sponsored by MED-Project LLC (regulated by the Massachusetts Department of Public Health). This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Save a search for “MED-Project LLC (regulated by the Massachusetts Department of Public Health)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
MED-Project Announces CalRecycle Full Approval of Covered Drugs and Sharps Take-Back Annual Reports The Medication Education & Disposal Project USA (MED-Project) announces that its 2023 Annual Reports for Covered Drugs and Home-Generated Sharps have been fully approved by the California Department of Resources Recycling and Recovery (CalRecycle).
MED-Project Announces CalRecycle Approval of Covered Drugs and Sharps Take-Back Annual Reports Medication Education & Disposal Project USA (MED-Project) announces that its 2022 Revised Annual Reports for Covered Drugs and Home-Generated Sharps have been approved by the California Department of Resources Recycling and Recovery (CalRecycle), the state’s oversight agency for recycling and waste management programs.
MED-Project Launches New Program to Provide Safe, Free, and Convenient Medication Disposal for California Residents California residents who rely on medication to treat medical conditions now have access to a free statewide program to dispose of medication safely and conveniently.
MED-Project Receives Approval from CalRecycle of First Annual Report for Sharps Take-Back Program The Medication Education & Disposal Project (MED-Project USA), a non-profit organization that provides statewide medication and sharps take-back programs, received approval of its first annual report for the Home Generated Sharps Waste Program on November 15, 2022.
MED-Project Launching Safe, Free, and Convenient Household Sharps Take-Back Program California residents who rely on syringes and injectable pharmaceutical products to treat health conditions now have access to MED-Project’s free, statewide program to safely dispose of household sharps.
MED-Project Receives Approval from CalRecycle of First Annual Report Submission This free statewide program helps California residents dispose of medication safely and conveniently.
MED-Project Approved to Launch Statewide Program to Provide Safe Medication Disposal to New York Residents State of New York – The Medication Education & Disposal Project (MED-Project) today announced its approval from the New York Department of Health to provide a free, statewide program and public education campaign to help New York residents dispose of medicine safely and conveniently.
Based on current listing details, eligibility includes: Law Enforcement Agencies (LEAs) within the Commonwealth of Massachusetts Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $650 - $1300 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.